^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in sterile water for injection.

^d Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture.

^e Tested in sodium chloride 0.45%.

^f Tested in Ringer’s injection, lactated.

^g Tested in both dextrose 5% and sodium chloride 0.9%.

^h Quinupristin and dalfopristin components combined.

ⁱ Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^j Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^k Test performed using the lactate salt formulation.

^l As midazolam base rather than the salt.

^m Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

ⁿ Test performed using the formulation WITHOUT edetate disodium.

^o Imipenem component. Imipenem in a 1:1 fixed-ratio concentration with cilastatin.

^p Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^q Tested as the premixed infusion solution.

^r Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.